On June 16, 2022, Shenzhen Living Water POCT held a strategic investment cooperation signing ceremony with 6 companies including BGI Co-Win, NEVC, Ruihai Invest, VDO Biotech, Zhouyu Fund, Great Wall fund.

After the completion of this financing, LW POCT will take CDMO as its main business model and strive to become a leading life science instrument CDMO enterprise. The company provides customers with customized development and services of life science instruments, covering the entire life cycle of product development, design transformation, product registration, precision manufacturing, and after-sales maintenance.

Mr. Liu Yu, the founding partner of BGI Co-Win, said that it is very valuable for LW POCT to choose the CDMO strategy. During the capital winter, LW received RMB 100 million in financing from 6 high-level investment companies for the first time. It can be seen that the high recognition of the team and projects.

Professor Zhang Huisheng, an entrepreneurial mentor of LW POCT, said that the entire system including R&D, registration, production, and delivery has been continuously improved. During the CDMO cooperation process, it has been highly recognized by partners. To have better development of LW, we need to make high-quality products and innovative products. At the same time, we must deepen the technology and expand the products. In addition, we must conduct in-depth research and development on key components to solve the key industrial problems and provide customers with cost-effective products and services. The original mission of building LW company is to do meaningful things and achieve young people with dreams. We hope that more young people who agree with the concept of LW will join the big family.